Search research articles
Contact Us
Filters
Showing results (181-190 of 206) with videos related to
Page
of 21
Sort By:
Journal of the National Cancer Institute
|
September 4, 1996
Assessment of axillary lymph node involvement in breast cancer patients with positron emission tomography using radiolabeled 2-(fluorine-18)-fluoro-2-deoxy-D-glucose
N Avril, J Dose, F Jänicke, et al.
Gynakologisch-Geburtshilfliche Rundschau
|
January 1, 1995
[Prognostic significance of the S-phase and MIB1 (Ki-67) proliferation parameters in node-negative breast carcinoma]
N Harbeck, P Dettmar, Ch Thomssen, et al.
Journal of the American College of Cardiology
|
February 11, 1999
Gender differences in myocardial blood flow dynamics: lipid profile and hemodynamic effects
C S Duvernoy, C Meyer, V Seifert-Klauss, et al.
The International Journal of Biological Markers
|
April 14, 2000
A new approach to phenotyping disseminated tumor cells: methodological advances and clinical implications
F Noack, M Schmitt, J Bauer, et al.
Biochemical Society Transactions
|
February 1, 1992
Flow cytofluorometry in tumour cell receptor analysis. Survey of the literature and recent developments concerning the urokinase-type plasminogen activator (uPA)
N Chucholowski, M Schmitt, L Goretzki, et al.
Gynakologische Rundschau
|
January 1, 1981
[Infections during pregnancy in the puerperium]
H Graeff, H H Warnecke, V Preac-Mursic, et al.
Biological Chemistry
|
August 24, 2001
High level synthesis of recombinant soluble urokinase receptor (CD87) by ovarian cancer cells reduces intraperitoneal tumor growth and spread in nude mice
V Lutz, U Reuning, A Krüger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 14, 2000
Breast imaging with positron emission tomography and fluorine-18 fluorodeoxyglucose: use and limitations
N Avril, C A Rosé, M Schelling, et al.
European Journal of Biochemistry
|
May 1, 1996
Systematic mutational analysis of the receptor-binding region of the human urokinase-type plasminogen activator
V Magdolen, P Rettenberger, M Koppitz, et al.
Journal of the National Cancer Institute
|
June 21, 2001
Randomized adjuvant chemotherapy trial in high-risk, lymph node-negative breast cancer patients identified by urokinase-type plasminogen activator and plasminogen activator inhibitor type 1
F Jänicke, A Prechtl, C Thomssen, et al.
Page
of 21
Search research articles
Search
Showing results (181-190 of 206) with videos related to
Sort By:
Page
of 21
Journal of the National Cancer Institute
|
September 4, 1996
Assessment of axillary lymph node involvement in breast cancer patients with positron emission tomography using radiolabeled 2-(fluorine-18)-fluoro-2-deoxy-D-glucose
N Avril, J Dose, F Jänicke, et al.
Gynakologisch-Geburtshilfliche Rundschau
|
January 1, 1995
[Prognostic significance of the S-phase and MIB1 (Ki-67) proliferation parameters in node-negative breast carcinoma]
N Harbeck, P Dettmar, Ch Thomssen, et al.
Journal of the American College of Cardiology
|
February 11, 1999
Gender differences in myocardial blood flow dynamics: lipid profile and hemodynamic effects
C S Duvernoy, C Meyer, V Seifert-Klauss, et al.
The International Journal of Biological Markers
|
April 14, 2000
A new approach to phenotyping disseminated tumor cells: methodological advances and clinical implications
F Noack, M Schmitt, J Bauer, et al.
Biochemical Society Transactions
|
February 1, 1992
Flow cytofluorometry in tumour cell receptor analysis. Survey of the literature and recent developments concerning the urokinase-type plasminogen activator (uPA)
N Chucholowski, M Schmitt, L Goretzki, et al.
Gynakologische Rundschau
|
January 1, 1981
[Infections during pregnancy in the puerperium]
H Graeff, H H Warnecke, V Preac-Mursic, et al.
Biological Chemistry
|
August 24, 2001
High level synthesis of recombinant soluble urokinase receptor (CD87) by ovarian cancer cells reduces intraperitoneal tumor growth and spread in nude mice
V Lutz, U Reuning, A Krüger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 14, 2000
Breast imaging with positron emission tomography and fluorine-18 fluorodeoxyglucose: use and limitations
N Avril, C A Rosé, M Schelling, et al.
European Journal of Biochemistry
|
May 1, 1996
Systematic mutational analysis of the receptor-binding region of the human urokinase-type plasminogen activator
V Magdolen, P Rettenberger, M Koppitz, et al.
Journal of the National Cancer Institute
|
June 21, 2001
Randomized adjuvant chemotherapy trial in high-risk, lymph node-negative breast cancer patients identified by urokinase-type plasminogen activator and plasminogen activator inhibitor type 1
F Jänicke, A Prechtl, C Thomssen, et al.
Page
of 21